InBody Co.Ltd (041830) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Based on the latest financial reports, InBody Co.Ltd (041830) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.04 Billion ≈ $6.13 Million USD) by net assets (₩282.02 Billion ≈ $191.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is InBody Co.Ltd's balance sheet to measure how much of total assets are equity-financed.

InBody Co.Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how InBody Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check InBody Co.Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

InBody Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of InBody Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Blue Label Telecoms Ltd JSE:BLU	0.456x
Gigalane Co Ltd KQ:049080	-0.089x
IGG Inc F:I91	-0.006x
Share India Securities Limited NSE:SHAREINDIA	-0.081x
Jtekt India Limited NSE:JTEKTINDIA	0.020x
Dezhou United Petroleum Technology Co.Ltd. SHE:301158	0.014x
Beijing Hezong Science&Technology Co Ltd SHE:300477	0.068x
Cedar Woods Properties Ltd AU:CWP	0.159x

Annual Cash Flow Conversion Efficiency for InBody Co.Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of InBody Co.Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of InBody Co.Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩273.90 Billion ≈ $185.62 Million	₩28.58 Billion ≈ $19.37 Million	0.104x	-32.63%
2023-12-31	₩249.83 Billion ≈ $169.31 Million	₩38.69 Billion ≈ $26.22 Million	0.155x	+9.58%
2022-12-31	₩215.26 Billion ≈ $145.88 Million	₩30.42 Billion ≈ $20.61 Million	0.141x	-14.45%
2021-12-31	₩183.73 Billion ≈ $124.51 Million	₩30.35 Billion ≈ $20.57 Million	0.165x	-13.02%
2020-12-31	₩150.06 Billion ≈ $101.70 Million	₩28.50 Billion ≈ $19.31 Million	0.190x	+9.60%
2019-12-31	₩139.69 Billion ≈ $94.67 Million	₩24.21 Billion ≈ $16.40 Million	0.173x	+21.74%
2018-12-31	₩124.39 Billion ≈ $84.29 Million	₩17.70 Billion ≈ $12.00 Million	0.142x	-18.41%
2017-12-31	₩106.48 Billion ≈ $72.16 Million	₩18.58 Billion ≈ $12.59 Million	0.174x	-11.71%
2016-12-31	₩92.30 Billion ≈ $62.55 Million	₩18.24 Billion ≈ $12.36 Million	0.198x	+34.91%
2015-12-31	₩76.32 Billion ≈ $51.72 Million	₩11.18 Billion ≈ $7.58 Million	0.146x	-14.89%
2014-12-31	₩59.61 Billion ≈ $40.40 Million	₩10.26 Billion ≈ $6.95 Million	0.172x	+26.86%
2013-12-31	₩51.56 Billion ≈ $34.94 Million	₩6.99 Billion ≈ $4.74 Million	0.136x	+43.70%
2012-12-31	₩46.13 Billion ≈ $31.26 Million	₩4.36 Billion ≈ $2.95 Million	0.094x	-27.61%
2011-12-31	₩42.14 Billion ≈ $28.56 Million	₩5.50 Billion ≈ $3.72 Million	0.130x	--

About InBody Co.Ltd

KQ:041830 Korea Healthcare Equipment & Supplies

Market Cap

$422.13 Million

₩622.90 Billion KRW

Market Cap Rank

#12912 Global

#347 in Korea

Share Price

₩46200.00

Change (1 day)

-0.96%

52-Week Range

₩25050.00 - ₩62000.00

All Time High

₩62000.00